Vexanac-AP Tablet
245,00 ₹
Analogs of Vexanac-AP Tablet
Find cheaper analogs and generic equivalents for Vexanac-AP Tablet.
Wirkstoff: Acebrophylline; Acetylcysteine
Produktübersicht
About Vexanac-AP Tablet
Vexanac-AP Tablet is a prescription medication that combines two active substances, Acebrophylline and Acetylcysteine, to support respiratory health. The formulation is designed to assist patients with conditions that involve mucus buildup and airway inflammation. Each tablet delivers a balanced dose of both active ingredients, providing a dual mechanism of action that can help improve breathing comfort and reduce mucus viscosity. The product is manufactured under strict quality controls to ensure consistency and safety for patients who require reliable respiratory support.
Key Benefits & Uses
- Helps reduce mucus thickness in the airways.
- Supports bronchodilation and airway clearance.
- Can be used as part of a comprehensive treatment plan for chronic respiratory conditions.
Active Ingredient & Action
Each Vexanac-AP Tablet contains Acebrophylline, a bronchodilator that relaxes smooth muscle in the airways, and Acetylcysteine, a mucolytic agent that breaks down thick mucus, making it easier to cough up. The combination of these two mechanisms can provide more effective relief for patients experiencing airway obstruction and mucus accumulation.
Important Notes
Vexanac-AP Tablet should be taken exactly as prescribed by a healthcare professional. Patients should inform their doctor of any other medications they are taking to avoid potential interactions. The medication is not intended for use in children under the age of 12 unless specifically directed by a physician. Store the tablets in a cool, dry place and keep them out of reach of children. If you experience any unusual symptoms or side effects, contact your healthcare provider promptly.
Find in Pharmacies
Compare local prices and distance for Vexanac-AP Tablet.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.